ATI Hematology Practice Exam

Disseminated intravascular coagulation (DIC) is indeed characterized by abnormal coagulation processes involving fibrinogen, among other factors. In DIC, there is widespread activation of the coagulation cascade, leading to the formation of fibrin clots throughout the small blood vessels. This excessive clotting can deplete platelets and clotting factors, causing a paradoxical increased risk of bleeding. The involvement of fibrinogen is crucial as it is a key protein in the coagulation process that is consumed during the formation of clots, leading to decreased levels in the bloodstream.

In this context, the accuracy of the statement is grounded in the understanding of DIC as a complex disorder that disrupts normal hemostasis and involves various components of the coagulation system. Recognizing the role of fibrinogen helps illustrate why patients with DIC present with a unique clinical picture, characterized by a bleeding tendency despite the presence of clotting.